Lotus Eye Hospital and Institute Share Price
Start SIP in Lotus Eye Hospital and Institute
Start SIPLotus Eye Hospital and Institute Performance
Day Range
- Low 72
- High 75
52 Week Range
- Low 49
- High 111
- Open Price75
- Previous Close73
- Volume37170
Lotus Eye Hospital And Institute Investment Rating
-
Master Rating:
-
Lotus Eye Hospital And Institute has an operating revenue of Rs. 48.53 Cr. on a trailing 12-month basis. An annual revenue growth of 3% is not great, Pre-tax margin of 8% is okay, ROE of 4% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 6% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 45 which is a POOR score indicating inconsistency in earnings, a RS Rating of 31 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 106 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 13 | 11 | 12 | 13 | 13 | 11 |
| Operating Expenses Qtr Cr | 11 | 10 | 10 | 11 | 10 | 10 |
| Operating Profit Qtr Cr | 2 | 1 | 2 | 2 | 2 | 1 |
| Depreciation Qtr Cr | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 | 1 | 0 |
| Net Profit Qtr Cr | 1 | 0 | 1 | 1 | 1 | 1 |
Lotus Eye Hospital and Institute Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 7
- Bearish Moving Average
- ___
- 9
- 20 Day
- ₹75.36
- 50 Day
- ₹72.14
- 100 Day
- ₹69.53
- 200 Day
- ₹70.20
- 20 Day
- ₹76.41
- 50 Day
- ₹71.94
- 100 Day
- ₹65.82
- 200 Day
- ₹69.63
Lotus Eye Hospital and Institute Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 75.11 |
| Second Resistance | 76.85 |
| Third Resistance | 78.91 |
| RSI | 46.30 |
| MFI | 63.48 |
| MACD Single Line | 1.57 |
| MACD | 0.77 |
| Support | |
|---|---|
| First Support | 71.31 |
| Second Support | 69.25 |
| Third Supoort | 67.51 |
Lotus Eye Hospital and Institute Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 42,643 | 2,700,155 | 63.32 |
| Week | 42,285 | 2,319,310 | 54.85 |
| 1 Month | 155,778 | 8,172,088 | 52.46 |
| 6 Month | 123,304 | 6,472,241 | 52.49 |
Lotus Eye Hospital and Institute Result Highlights
Lotus Eye Hospital and Institute Synopsis
NSE-Medical-Hospitals
Lotus Eye Hospital belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 48.21 Cr. and Equity Capital is Rs. 20.80 Cr. for the Year ended 31/03/2024. Lotus Eye Hospital and Institute Ltd. is a Public Limited Listed company incorporated on 14/03/1997 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L85110TZ1997PLC007783 and registration number is 007783.| Market Cap | 153 |
| Sales | 49 |
| Shares in Float | 1.25 |
| No of funds | 1 |
| Yield | 0.82 |
| Book Value | 2.57 |
| U/D Vol ratio | 2.3 |
| LTDebt / Equity | |
| Alpha | -0.1 |
| Beta | 0.81 |
Lotus Eye Hospital and Institute Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 40.24% | 41.4% | 56.58% | 57.58% |
| Individual Investors | 43.82% | 42.47% | 24.08% | 22.95% |
| Others | 15.94% | 16.13% | 19.34% | 19.47% |
Lotus Eye Hospital and Institute Management
| Name | Designation |
|---|---|
| Dr. Kavetha Sundaramoorthy | Chairman |
| Ms. Sangeetha Sundaramoorthy | Managing Director |
| Dr. K S Ramalingam | WholeTime Director & CEO |
| Dr. S Natesan | Director |
| CA. Perumalsamy Mahendran | Director |
| CA. M Alagiriswamy | Director |
| Mr. Karthik Veeramani | Director |
| Mr. D R Kaarthikeyan | Director |
| Dr. Yogesh Shah | Director |
Lotus Eye Hospital and Institute Forecast
Price Estimates
Lotus Eye Hospital and Institute Corporate Action
Lotus Eye Hospital and Institute FAQs
What is Share Price of Lotus Eye Hospital and Institute ?
Lotus Eye Hospital and Institute share price is ₹73 As on 20 September, 2024 | 15:20
What is the Market Cap of Lotus Eye Hospital and Institute ?
The Market Cap of Lotus Eye Hospital and Institute is ₹151.8 Cr As on 20 September, 2024 | 15:20
What is the P/E ratio of Lotus Eye Hospital and Institute ?
The P/E ratio of Lotus Eye Hospital and Institute is 70.5 As on 20 September, 2024 | 15:20
What is the PB ratio of Lotus Eye Hospital and Institute ?
The PB ratio of Lotus Eye Hospital and Institute is 2.6 As on 20 September, 2024 | 15:20